Helius Medical Shares Rise 10% After Partnership With Lovell Govt Services

Dow Jones04-04
 

By Chris Wack

 

Helius Medical Technologies shares were up 10% to $6.25 after the company said it has partnered with Lovell Government Services, an SBA-certified Service Disabled Veteran Owned Small Business, to make its portable neuromodulation stimulator device available to federal healthcare systems.

The stock hit its 52-week low of $4.29 on Feb. 28, and is down 49% in the past 12 months.

The portable neuromodulation stimulator is allowed in the U.S. for use as a short-term treatment of gait deficit in adults with mild to moderate symptoms from multiple sclerosis when used in conjunction with physical therapy.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

April 03, 2024 12:49 ET (16:49 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment